These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 34133849)

  • 1. Synaptic density in carriers of C9orf72 mutations: a [
    Malpetti M; Holland N; Jones PS; Ye R; Cope TE; Fryer TD; Hong YT; Savulich G; Rittman T; Passamonti L; Mak E; Aigbirhio FI; O'Brien JT; Rowe JB
    Ann Clin Transl Neurol; 2021 Jul; 8(7):1515-1523. PubMed ID: 34133849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synaptic Loss in Frontotemporal Dementia Revealed by [
    Malpetti M; Jones PS; Cope TE; Holland N; Naessens M; Rouse MA; Rittman T; Savulich G; Whiteside DJ; Street D; Fryer TD; Hong YT; Milicevic Sephton S; Aigbirhio FI; O Brien JT; Rowe JB
    Ann Neurol; 2023 Jan; 93(1):142-154. PubMed ID: 36321699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synaptic density in healthy human aging is not influenced by age or sex: a
    Michiels L; Delva A; van Aalst J; Ceccarini J; Vandenberghe W; Vandenbulcke M; Koole M; Lemmens R; Laere KV
    Neuroimage; 2021 May; 232():117877. PubMed ID: 33639258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal imaging in
    Floeter MK; Bageac D; Danielian LE; Braun LE; Traynor BJ; Kwan JY
    Neuroimage Clin; 2016; 12():1035-1043. PubMed ID: 27995069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneous brain FDG-PET metabolic patterns in patients with C9orf72 mutation.
    Castelnovo V; Caminiti SP; Riva N; Magnani G; Silani V; Perani D
    Neurol Sci; 2019 Mar; 40(3):515-521. PubMed ID: 30554355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohort.
    Van Mossevelde S; van der Zee J; Gijselinck I; Engelborghs S; Sieben A; Van Langenhove T; De Bleecker J; Baets J; Vandenbulcke M; Van Laere K; Ceyssens S; Van den Broeck M; Peeters K; Mattheijssens M; Cras P; Vandenberghe R; De Jonghe P; Martin JJ; De Deyn PP; Cruts M; Van Broeckhoven C;
    Brain; 2016 Feb; 139(Pt 2):452-67. PubMed ID: 26674655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced synaptic vesicle protein 2A binding in temporal lobe epilepsy: A [
    Finnema SJ; Toyonaga T; Detyniecki K; Chen MK; Dias M; Wang Q; Lin SF; Naganawa M; Gallezot JD; Lu Y; Nabulsi NB; Huang Y; Spencer DD; Carson RE
    Epilepsia; 2020 Oct; 61(10):2183-2193. PubMed ID: 32944949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bifrontal Hypermetabolism on Brain FDG-PET in a Case of C9orf72-Related Behavioral Variant of Frontotemporal Dementia.
    Levy JP; Bocti C; Elie D; Paquet N; Soucy JP; Ducharme S
    J Neuropsychiatry Clin Neurosci; 2019; 31(1):92-94. PubMed ID: 30404533
    [No Abstract]   [Full Text] [Related]  

  • 9. 18F-MK-6240 tau-PET in genetic frontotemporal dementia.
    Levy JP; Bezgin G; Savard M; Pascoal TA; Finger E; Laforce R; Sonnen JA; Soucy JP; Gauthier S; Rosa-Neto P; Ducharme S
    Brain; 2022 Jun; 145(5):1763-1772. PubMed ID: 34664612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDG-PET in presymptomatic C9orf72 mutation carriers.
    Popuri K; Beg MF; Lee H; Balachandar R; Wang L; Sossi V; Jacova C; Baker M; Shahinfard E; Rademakers R; Mackenzie IRA; Hsiung GR
    Neuroimage Clin; 2021; 31():102687. PubMed ID: 34049163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo imaging of synaptic density with [
    Xiong M; Roshanbin S; Rokka J; Schlein E; Ingelsson M; Sehlin D; Eriksson J; Syvänen S
    Neuroimage; 2021 Oct; 239():118302. PubMed ID: 34174391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update on genetic frontotemporal dementia.
    Greaves CV; Rohrer JD
    J Neurol; 2019 Aug; 266(8):2075-2086. PubMed ID: 31119452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C9orf72-specific phenomena associated with frontotemporal dementia and gastrointestinal symptoms in the absence of TDP-43 aggregation.
    Sampognaro PJ; Vatsavayai SC; Cosme CG; Hwang JL; Nolan A; Huang EJ; Seeley WW; De May MG
    Acta Neuropathol; 2019 Dec; 138(6):1093-1097. PubMed ID: 31624869
    [No Abstract]   [Full Text] [Related]  

  • 14. Faster Cortical Thinning and Surface Area Loss in Presymptomatic and Symptomatic C9orf72 Repeat Expansion Adult Carriers.
    Le Blanc G; Jetté Pomerleau V; McCarthy J; Borroni B; van Swieten J; Galimberti D; Sanchez-Valle R; LaForce R; Moreno F; Synofzik M; Graff C; Masellis M; Tartaglia MC; Rowe JB; Vandenberghe R; Finger E; Tagliavini F; de Mendonça A; Santana I; Butler C; Gerhard A; Danek A; Levin J; Otto M; Frisoni G; Sorbi S; Rohrer JD; Ducharme S;
    Ann Neurol; 2020 Jul; 88(1):113-122. PubMed ID: 32285980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal variant of frontotemporal dementia in C9orf72 repeat expansion carriers: two case studies.
    Caso F; Agosta F; Magnani G; Cardamone R; Borghesani V; Miller Z; Riva N; La Joie R; Coppola G; Grinberg LT; Seeley WW; Miller BL; Gorno-Tempini ML; Filippi M
    Brain Imaging Behav; 2020 Apr; 14(2):336-345. PubMed ID: 32180125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synaptic dysfunction and altered excitability in C9ORF72 ALS/FTD.
    Starr A; Sattler R
    Brain Res; 2018 Aug; 1693(Pt A):98-108. PubMed ID: 29453960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal pain perception is associated with thalamo-cortico-striatal atrophy in
    Convery RS; Bocchetta M; Greaves CV; Moore KM; Cash DM; Van Swieten J; Moreno F; Sánchez-Valle R; Borroni B; Laforce R; Masellis M; Tartaglia MC; Graff C; Galimberti D; Rowe JB; Finger E; Synofzik M; Vandenberghe R; de Mendonca A; Tagliavini F; Santana I; Ducharme S; Butler C; Gerhard A; Levin J; Danek A; Otto M; Warren JD; Rohrer JD;
    J Neurol Neurosurg Psychiatry; 2020 Dec; 91(12):1325-1328. PubMed ID: 32759310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Multimodal Imaging and Clinical Biomarkers in Presymptomatic Carriers of C9orf72 Repeat Expansion.
    De Vocht J; Blommaert J; Devrome M; Radwan A; Van Weehaeghe D; De Schaepdryver M; Ceccarini J; Rezaei A; Schramm G; van Aalst J; Chiò A; Pagani M; Stam D; Van Esch H; Lamaire N; Verhaegen M; Mertens N; Poesen K; van den Berg LH; van Es MA; Vandenberghe R; Vandenbulcke M; Van den Stock J; Koole M; Dupont P; Van Laere K; Van Damme P
    JAMA Neurol; 2020 Aug; 77(8):1008-1017. PubMed ID: 32421156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel antibodies reveal presynaptic localization of C9orf72 protein and reduced protein levels in C9orf72 mutation carriers.
    Frick P; Sellier C; Mackenzie IRA; Cheng CY; Tahraoui-Bories J; Martinat C; Pasterkamp RJ; Prudlo J; Edbauer D; Oulad-Abdelghani M; Feederle R; Charlet-Berguerand N; Neumann M
    Acta Neuropathol Commun; 2018 Aug; 6(1):72. PubMed ID: 30075745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schizophrenia Phenotype Preceding Behavioral Variant Frontotemporal Dementia Related to C9orf72 Repeat Expansion.
    Sellami L; St-Onge F; Poulin S; Laforce R
    Cogn Behav Neurol; 2019 Jun; 32(2):120-123. PubMed ID: 31205123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.